References
- Prego C , GarciaM, TorresD, AlonsoMJ. Transmucosal macromolecular drug delivery. J. Control. Release101(1–3), 151–162 (2005).
- Luppi B , BigucciF, CerchiaraT, ZecchiV. Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles. Expert Opin. Drug Deliv.7(7), 811–828 (2010).
- Duan XP , MaoSR. New strategies to improve the intranasal absorption of insulin. Drug Discov. Today15(11–12), 416–427 (2010).
- Blanchette J , KavimandanN, PeppasNA. Principles of transmucosal delivery of therapeutic agents. Biomed. Pharmacother.58(3), 142–151 (2004).
- Khutoryanskiy VV . Advanced in mucoadhesion and mucoadhesive polymers. Macromol. Biosci.11, 748–764 (2011).
- Morimoto K , MorisakaK, KamadaA. Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel. J. Pharm. Pharmacol.37, 134–136 (1985).
- du Plessis L , KotzeA, JungingerH. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride. Drug Deliv.17, 399–407 (2010).
- Agrawal AK , GuptaPN, KhannaAet al. Development and characterisation of in situ gel system for nasal insulin delivery. Pharmazie 65, 188–193 (2010).
- Chung T -W, Liu D-Z, Yang J-S. Effects of interpenetration of thermosensitive gels by cross-linking of chitosan on nasal delivery of insulin: in vitro charactersation and in vivo study. Carbohyd. Polym.82, 316–322 (2010).
- Luppi B , BigucciF, CerchiaraT, ZecchiV. Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles. Expert Opin. Drug Deliv.7, 811–828 (2010).
- Wu J , WeiW, Wang L-Y, Su Z-G, Ma G-H. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system. Biomaterials28, 2220–2232 (2007).
- Varshosaz J , SadraiH, HeidariA. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv.13, 31–38 (2006).
- Rao SB , SharmaCP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J. Biomed. Mater. Res.34, 21–28 (1997).
- Chen R , ChenHC. Chitin enzymology-chitinase. Adv. Chitin Sci.3, 16–23 (1998).
- Muzzarelli C . Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell. Mol. Life Sci.53, 131–140 (1997).
- Hirano S , SeinoH, AkiyamaY, NonakaI. Biocompatibility of chitosan by oral and intravenous administrations. Poly. Eng. Sci.59, 897–901(1988).
- Lehr C -M, Bouwstra JA, Schacht EH. In-vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm.78, 43–48 (1992).
- Nazar H , FatourosDG, van der Merwe SM et al. Thermosensitive hydrogels for nasal drug delivery: the formulation and characterisation of systems based on N-trimethyl chitosan chloride. Eur. J. Pharm. Biopharm.77, 225–232 (2011).
- Barichello JM , MorishitaM, NagaiKTT. Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats. Int. J. Pharm.184, 189–198 (1999).
- Dyer AM , HinchcliffeM, WattsPet al. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm. Res. 19, 998–1008 (2002).